Cart
sales@molnova.com
HDAC-IN-52
CAS No. 2075787-77-6
HDAC-IN-52( —— )
Catalog No. M36045 CAS No. 2075787-77-6
HDAC-IN-52, a pyridine-containing HDAC inhibitor, effectively inhibits HDAC1, HDAC2, HDAC3, and HDAC10 with IC50 values of 0.189, 0.227, 0.440, and 0.446 μM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 269 | Get Quote |
|
| 5MG | 372 | Get Quote |
|
| 10MG | 558 | Get Quote |
|
| 25MG | 821 | Get Quote |
|
| 50MG | 1122 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 200MG | 2007 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHDAC-IN-52
-
NoteResearch use only, not for human use.
-
Brief DescriptionHDAC-IN-52, a pyridine-containing HDAC inhibitor, effectively inhibits HDAC1, HDAC2, HDAC3, and HDAC10 with IC50 values of 0.189, 0.227, 0.440, and 0.446 μM, respectively.
-
DescriptionHDAC-IN-52 is a pyridine-containing HDAC inhibitor, with IC50s of 0.189, 0.227, 0.440 and 0.446 μM for HDAC1, HDAC2, HDAC3, and HDAC10, respectively. HDAC-IN-52 can be used for the research of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2075787-77-6
-
Formula Weight396.44
-
Molecular FormulaC24H20N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(NC=1C=CC(C(NC2=C(N)C=CC=C2)=O)=NC1)=O)C3=CC4=C(C=C3)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bello ED, et, al. Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. Eur J Med Chem. 2022 Dec 15;247:115022.?
molnova catalog
related products
-
MC-1568
A potent and selective class IIa HDAC inhibitor with IC50 of 220 nM for maize HD1-A.
-
HPOB
A potent and selective HDAC6 inhibitor (IC50=56 nM).
-
JAK/HDAC-IN-1
JAK/HDAC-IN-1 is an effective JAK2/HDAC dual inhibitor (IC50s: 4 and 2 nM for JAK2 and HDAC). It also shows antiproliferative and proapoptotic activities in several hematological cell lines.
